AIVITA Biomedical Scientists Invited to Deliver Keynote Address at HAPPI Anti-Aging Conference

Date: Mar 13, 2018

IRVINE, Calif. – March 14, 2018 – AIVITA Biomedical, a global biotech specializing in innovative stem cell applications, announced today the appointment of two senior scientists as keynote speakers at the HAPPI Anti-Aging Conference. Chief Science Officer Gabriel Nistor, M.D. and Vice President of Research and Development Aleksandra J. Poole, Ph.D. will deliver a keynote speech titled Biotechnology-derived Active Ingredients for Anti-Aging Cosmetics at the conference taking place May 15-16 at the Jacob Javits Convention Center in New York City.

HAPPI is the leading media outlet in the global personal care and household product market. HAPPI’s Anti-Aging Conference will give formulators and their suppliers an opportunity to learn, interact and discuss all things related to anti-aging with industry professionals. The conference will feature breakthrough technology, novel raw materials, regulatory insights and market research involving the multibillion-dollar anti-aging industry.

In January Dr. Nistor and Dr. Poole introduced to consumers an all-new actives complex which utilizes the natural signaling methods and ingredients of skin stem cells to achieve more youthful-looking skin. The breakthrough active is available in the Company’s ROOT OF SKIN™ product line.

“We’re grateful for the invitation and look forward to sharing some truly exciting innovations with the attendees,” said Dr. Nistor. “We hope our focus on providing proper nutriments to achieve results is a welcome shift from current, more damaging approaches.”

Dr. Hans Keirstead, CEO of AIVITA Biomedical, will also appear on a promotional podcast with host Tom Branna in advance of the show, which will be made available on and


ROOT OF SKIN™ is the world’s first skin care product formulated and marketed for use by both women and men. Created by AIVITA Biomedical, the ROOT OF SKIN™ patent-pending proprietary actives complex, SourceCode Technology™, is the result of decades of leading research in human stem cell-based cancer therapies. SourceCode Technology™ is exclusively manufactured in AIVITA Biomedical’s clinical grade research facilities and is available only in ROOT OF SKIN™ products.  All proceeds from the sale of ROOT OF SKIN products support the treatment of women with ovarian cancer.

About AIVITA Biomedical

AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its commercial line of skin care products and therapeutic pipeline.